nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.164	0.366	CbGbCtD
Repaglinide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0716	0.159	CbGbCtD
Repaglinide—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.069	0.154	CbGbCtD
Repaglinide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0665	0.148	CbGbCtD
Repaglinide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0306	0.0681	CbGbCtD
Repaglinide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.028	0.0624	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0191	0.0425	CbGbCtD
Repaglinide—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.0121	0.728	CbGdCrCtD
Repaglinide—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00454	0.273	CbGdCrCtD
Repaglinide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00247	CcSEcCtD
Repaglinide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00247	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0013	0.00246	CcSEcCtD
Repaglinide—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00246	CcSEcCtD
Repaglinide—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00244	CcSEcCtD
Repaglinide—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00126	0.00238	CcSEcCtD
Repaglinide—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00237	CcSEcCtD
Repaglinide—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00237	CcSEcCtD
Repaglinide—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00236	CcSEcCtD
Repaglinide—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00236	CcSEcCtD
Repaglinide—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00236	CcSEcCtD
Repaglinide—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00235	CcSEcCtD
Repaglinide—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00232	CcSEcCtD
Repaglinide—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00232	CcSEcCtD
Repaglinide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00122	0.00232	CcSEcCtD
Repaglinide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00122	0.00232	CcSEcCtD
Repaglinide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00231	CcSEcCtD
Repaglinide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00122	0.0023	CcSEcCtD
Repaglinide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00121	0.0023	CcSEcCtD
Repaglinide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.0023	CcSEcCtD
Repaglinide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00229	CcSEcCtD
Repaglinide—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00229	CcSEcCtD
Repaglinide—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00229	CcSEcCtD
Repaglinide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00229	CcSEcCtD
Repaglinide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00229	CcSEcCtD
Repaglinide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00229	CcSEcCtD
Repaglinide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.0012	0.00228	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00227	CcSEcCtD
Repaglinide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0012	0.00227	CcSEcCtD
Repaglinide—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00119	0.00225	CcSEcCtD
Repaglinide—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00118	0.00223	CcSEcCtD
Repaglinide—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00118	0.00223	CcSEcCtD
Repaglinide—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00223	CcSEcCtD
Repaglinide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00219	CcSEcCtD
Repaglinide—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00219	CcSEcCtD
Repaglinide—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00115	0.00217	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00114	0.00215	CcSEcCtD
Repaglinide—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00215	CcSEcCtD
Repaglinide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00113	0.00215	CcSEcCtD
Repaglinide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00215	CcSEcCtD
Repaglinide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00112	0.00213	CcSEcCtD
Repaglinide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.00213	CcSEcCtD
Repaglinide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00213	CcSEcCtD
Repaglinide—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00112	0.00213	CcSEcCtD
Repaglinide—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00111	0.00211	CcSEcCtD
Repaglinide—Oedema—Vincristine—peripheral nervous system neoplasm	0.00111	0.00211	CcSEcCtD
Repaglinide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00111	0.0021	CcSEcCtD
Repaglinide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00109	0.00207	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00207	CcSEcCtD
Repaglinide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00109	0.00206	CcSEcCtD
Repaglinide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00205	CcSEcCtD
Repaglinide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00205	CcSEcCtD
Repaglinide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00205	CcSEcCtD
Repaglinide—Back pain—Etoposide—peripheral nervous system neoplasm	0.00107	0.00203	CcSEcCtD
Repaglinide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00107	0.00202	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00202	CcSEcCtD
Repaglinide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.002	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.002	CcSEcCtD
Repaglinide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00105	0.00199	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00199	CcSEcCtD
Repaglinide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00198	CcSEcCtD
Repaglinide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00198	CcSEcCtD
Repaglinide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00197	CcSEcCtD
Repaglinide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00103	0.00195	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00193	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00193	CcSEcCtD
Repaglinide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00193	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00102	0.00192	CcSEcCtD
Repaglinide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.001	0.0019	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000999	0.00189	CcSEcCtD
Repaglinide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00099	0.00188	CcSEcCtD
Repaglinide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.00187	CcSEcCtD
Repaglinide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000986	0.00187	CcSEcCtD
Repaglinide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000986	0.00187	CcSEcCtD
Repaglinide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000986	0.00187	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000985	0.00187	CcSEcCtD
Repaglinide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000978	0.00185	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000976	0.00185	CcSEcCtD
Repaglinide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000971	0.00184	CcSEcCtD
Repaglinide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000971	0.00184	CcSEcCtD
Repaglinide—Rash—Topotecan—peripheral nervous system neoplasm	0.00097	0.00184	CcSEcCtD
Repaglinide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000969	0.00184	CcSEcCtD
Repaglinide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000965	0.00183	CcSEcCtD
Repaglinide—Headache—Topotecan—peripheral nervous system neoplasm	0.000964	0.00183	CcSEcCtD
Repaglinide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000962	0.00182	CcSEcCtD
Repaglinide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000962	0.00182	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000962	0.00182	CcSEcCtD
Repaglinide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000962	0.00182	CcSEcCtD
Repaglinide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000962	0.00182	CcSEcCtD
Repaglinide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000958	0.00181	CcSEcCtD
Repaglinide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000957	0.00181	CcSEcCtD
Repaglinide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000956	0.00181	CcSEcCtD
Repaglinide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000956	0.00181	CcSEcCtD
Repaglinide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000955	0.00181	CcSEcCtD
Repaglinide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000953	0.00181	CcSEcCtD
Repaglinide—Rash—Melphalan—peripheral nervous system neoplasm	0.00095	0.0018	CcSEcCtD
Repaglinide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000949	0.0018	CcSEcCtD
Repaglinide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000946	0.00179	CcSEcCtD
Repaglinide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000942	0.00178	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000936	0.00177	CcSEcCtD
Repaglinide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000919	0.00174	CcSEcCtD
Repaglinide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000919	0.00174	CcSEcCtD
Repaglinide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000915	0.00173	CcSEcCtD
Repaglinide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000914	0.00173	CcSEcCtD
Repaglinide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000912	0.00173	CcSEcCtD
Repaglinide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000907	0.00172	CcSEcCtD
Repaglinide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000907	0.00172	CcSEcCtD
Repaglinide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000903	0.00171	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000898	0.0017	CcSEcCtD
Repaglinide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000895	0.0017	CcSEcCtD
Repaglinide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000885	0.00168	CcSEcCtD
Repaglinide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000884	0.00167	CcSEcCtD
Repaglinide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000881	0.00167	CcSEcCtD
Repaglinide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000877	0.00166	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000873	0.00165	CcSEcCtD
Repaglinide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000867	0.00164	CcSEcCtD
Repaglinide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00162	CcSEcCtD
Repaglinide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000854	0.00162	CcSEcCtD
Repaglinide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000852	0.00161	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000851	0.00161	CcSEcCtD
Repaglinide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000821	0.00156	CcSEcCtD
Repaglinide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000818	0.00155	CcSEcCtD
Repaglinide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000811	0.00154	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000808	0.00153	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000803	0.00152	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000802	0.00152	CcSEcCtD
Repaglinide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000793	0.0015	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.0015	CcSEcCtD
Repaglinide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000792	0.0015	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000787	0.00149	CcSEcCtD
Repaglinide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000787	0.00149	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00078	0.00148	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000774	0.00147	CcSEcCtD
Repaglinide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000772	0.00146	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000771	0.00146	CcSEcCtD
Repaglinide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000763	0.00144	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000751	0.00142	CcSEcCtD
Repaglinide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000745	0.00141	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.00141	CcSEcCtD
Repaglinide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000741	0.0014	CcSEcCtD
Repaglinide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000738	0.0014	CcSEcCtD
Repaglinide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000736	0.00139	CcSEcCtD
Repaglinide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.00138	CcSEcCtD
Repaglinide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.00138	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.00138	CcSEcCtD
Repaglinide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000726	0.00138	CcSEcCtD
Repaglinide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.00137	CcSEcCtD
Repaglinide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000717	0.00136	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000716	0.00136	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000714	0.00135	CcSEcCtD
Repaglinide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000714	0.00135	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000714	0.00135	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00135	CcSEcCtD
Repaglinide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000709	0.00134	CcSEcCtD
Repaglinide—Rash—Vincristine—peripheral nervous system neoplasm	0.000703	0.00133	CcSEcCtD
Repaglinide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000702	0.00133	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000702	0.00133	CcSEcCtD
Repaglinide—Headache—Vincristine—peripheral nervous system neoplasm	0.000698	0.00132	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000695	0.00132	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.00131	CcSEcCtD
Repaglinide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000687	0.0013	CcSEcCtD
Repaglinide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000687	0.0013	CcSEcCtD
Repaglinide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000674	0.00128	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00128	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000666	0.00126	CcSEcCtD
Repaglinide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000665	0.00126	CcSEcCtD
Repaglinide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000662	0.00125	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000661	0.00125	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.00125	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.00125	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.00123	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000644	0.00122	CcSEcCtD
Repaglinide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000639	0.00121	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00121	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.0012	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00063	0.00119	CcSEcCtD
Repaglinide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000627	0.00119	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00118	CcSEcCtD
Repaglinide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000622	0.00118	CcSEcCtD
Repaglinide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000621	0.00118	CcSEcCtD
Repaglinide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00117	CcSEcCtD
Repaglinide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00117	CcSEcCtD
Repaglinide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000618	0.00117	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.00117	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.00116	CcSEcCtD
Repaglinide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.0006	0.00114	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.00113	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.00112	CcSEcCtD
Repaglinide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000585	0.00111	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.0011	CcSEcCtD
Repaglinide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000574	0.00109	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00109	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00109	CcSEcCtD
Repaglinide—Rash—Etoposide—peripheral nervous system neoplasm	0.000569	0.00108	CcSEcCtD
Repaglinide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000569	0.00108	CcSEcCtD
Repaglinide—Headache—Etoposide—peripheral nervous system neoplasm	0.000566	0.00107	CcSEcCtD
Repaglinide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000555	0.00105	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.00105	CcSEcCtD
Repaglinide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000548	0.00104	CcSEcCtD
Repaglinide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000536	0.00102	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000535	0.00101	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000528	0.001	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000528	0.001	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000993	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000973	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.000961	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000959	CcSEcCtD
Repaglinide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000959	CcSEcCtD
Repaglinide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000939	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000939	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000931	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000926	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000926	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000919	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000887	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000887	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000874	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000869	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000862	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000861	CcSEcCtD
Repaglinide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000844	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000828	CcSEcCtD
Repaglinide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000433	0.00082	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000808	CcSEcCtD
Repaglinide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000797	CcSEcCtD
Repaglinide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000784	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000781	CcSEcCtD
Repaglinide—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000408	0.062	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000766	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000762	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000759	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000758	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000726	CcSEcCtD
Repaglinide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000706	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000705	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000701	CcSEcCtD
Repaglinide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000678	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000348	0.0529	CbGpPWpGaD
Repaglinide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000656	CcSEcCtD
Repaglinide—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000346	0.0526	CbGpPWpGaD
Repaglinide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000654	CcSEcCtD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000338	0.0513	CbGpPWpGaD
Repaglinide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000628	CcSEcCtD
Repaglinide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00061	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000607	CcSEcCtD
Repaglinide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000605	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000604	CcSEcCtD
Repaglinide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000601	CcSEcCtD
Repaglinide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00057	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000564	CcSEcCtD
Repaglinide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000559	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000559	CcSEcCtD
Repaglinide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000556	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000527	CcSEcCtD
Repaglinide—PPARG—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.000238	0.0362	CbGpPWpGaD
Repaglinide—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000223	0.0339	CbGpPWpGaD
Repaglinide—ABCC8—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000217	0.033	CbGpPWpGaD
Repaglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000163	0.0247	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000154	0.0234	CbGpPWpGaD
Repaglinide—ABCC8—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00015	0.0227	CbGpPWpGaD
Repaglinide—KCNJ11—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.000145	0.022	CbGpPWpGaD
Repaglinide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000126	0.0191	CbGpPWpGaD
Repaglinide—ABCC8—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00012	0.0183	CbGpPWpGaD
Repaglinide—ABCC8—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000118	0.0179	CbGpPWpGaD
Repaglinide—KCNJ11—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000117	0.0177	CbGpPWpGaD
Repaglinide—KCNJ11—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000114	0.0173	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000112	0.0171	CbGpPWpGaD
Repaglinide—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000107	0.0162	CbGpPWpGaD
Repaglinide—ABCC8—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	9.46e-05	0.0144	CbGpPWpGaD
Repaglinide—KCNJ11—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	9.17e-05	0.0139	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	7.33e-05	0.0111	CbGpPWpGaD
Repaglinide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	6.88e-05	0.0105	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CNTN6—peripheral nervous system neoplasm	6.27e-05	0.00954	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.13e-05	0.00931	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	6.07e-05	0.00923	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.64e-05	0.00857	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	5.6e-05	0.00851	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—BCHE—peripheral nervous system neoplasm	5.6e-05	0.00851	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.47e-05	0.00831	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—BCHE—peripheral nervous system neoplasm	5.43e-05	0.00825	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.42e-05	0.00824	CbGpPWpGaD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	5.08e-05	0.00772	CbGpPWpGaD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	4.93e-05	0.00749	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TH—peripheral nervous system neoplasm	4.9e-05	0.00745	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.82e-05	0.00733	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—MYC—peripheral nervous system neoplasm	4.59e-05	0.00698	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	4.36e-05	0.00663	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	4.3e-05	0.00654	CbGpPWpGaD
Repaglinide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.15e-05	0.0063	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	4.1e-05	0.00623	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.04e-05	0.00614	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.95e-05	0.00601	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.81e-05	0.00579	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.69e-05	0.00561	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	3.58e-05	0.00545	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—EED—peripheral nervous system neoplasm	3.51e-05	0.00533	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	3.41e-05	0.00519	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.19e-05	0.00484	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—peripheral nervous system neoplasm	3.19e-05	0.00484	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.18e-05	0.00483	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NCAM1—peripheral nervous system neoplasm	3.06e-05	0.00466	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.06e-05	0.00465	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.87e-05	0.00436	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	2.81e-05	0.00426	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.77e-05	0.00421	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.76e-05	0.00419	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GNS—peripheral nervous system neoplasm	2.75e-05	0.00418	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.73e-05	0.00415	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GNS—peripheral nervous system neoplasm	2.67e-05	0.00406	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NME1—peripheral nervous system neoplasm	2.64e-05	0.00401	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NME1—peripheral nervous system neoplasm	2.56e-05	0.00389	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—AKT1—peripheral nervous system neoplasm	2.54e-05	0.00386	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—COX2—peripheral nervous system neoplasm	2.54e-05	0.00386	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—COX2—peripheral nervous system neoplasm	2.46e-05	0.00374	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.31e-05	0.00351	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.27e-05	0.00345	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.27e-05	0.00344	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.15e-05	0.00327	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GNS—peripheral nervous system neoplasm	1.97e-05	0.003	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	1.91e-05	0.0029	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NME1—peripheral nervous system neoplasm	1.89e-05	0.00287	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.83e-05	0.00278	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.82e-05	0.00277	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—COX2—peripheral nervous system neoplasm	1.82e-05	0.00277	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.82e-05	0.00276	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.79e-05	0.00271	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.75e-05	0.00266	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ENO2—peripheral nervous system neoplasm	1.67e-05	0.00253	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	1.64e-05	0.00249	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.00246	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ENO2—peripheral nervous system neoplasm	1.62e-05	0.00246	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	1.59e-05	0.00242	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	1.55e-05	0.00236	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	1.49e-05	0.00226	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	1.46e-05	0.00223	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	1.43e-05	0.00218	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—BCHE—peripheral nervous system neoplasm	1.41e-05	0.00214	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	1.4e-05	0.00213	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—BCHE—peripheral nervous system neoplasm	1.37e-05	0.00208	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.35e-05	0.00206	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.00204	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TH—peripheral nervous system neoplasm	1.32e-05	0.00201	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—HRAS—peripheral nervous system neoplasm	1.31e-05	0.002	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.3e-05	0.00198	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.3e-05	0.00198	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TH—peripheral nervous system neoplasm	1.28e-05	0.00195	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.28e-05	0.00194	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.00194	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—HRAS—peripheral nervous system neoplasm	1.27e-05	0.00194	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.23e-05	0.00188	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.23e-05	0.00187	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.00182	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.00164	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.07e-05	0.00163	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.00161	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.06e-05	0.00161	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-05	0.00159	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-05	0.00156	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.03e-05	0.00156	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.02e-05	0.00155	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	1.01e-05	0.00154	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	9.84e-06	0.0015	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.81e-06	0.00149	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.63e-06	0.00146	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TH—peripheral nervous system neoplasm	9.49e-06	0.00144	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	9.41e-06	0.00143	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.25e-06	0.00141	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	8.93e-06	0.00136	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNS—peripheral nervous system neoplasm	8.88e-06	0.00135	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	8.6e-06	0.00131	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	8.56e-06	0.0013	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NME1—peripheral nervous system neoplasm	8.51e-06	0.00129	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	8.24e-06	0.00125	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	8.19e-06	0.00125	CbGpPWpGaD
Repaglinide—ALB—Metabolism—COX2—peripheral nervous system neoplasm	8.19e-06	0.00125	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.14e-06	0.00124	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	8.06e-06	0.00122	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	7.95e-06	0.00121	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	7.75e-06	0.00118	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	7.61e-06	0.00116	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.59e-06	0.00115	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	7.48e-06	0.00114	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.45e-06	0.00113	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.31e-06	0.00111	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.63e-06	0.00101	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	6.1e-06	0.000928	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.99e-06	0.00091	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	5.98e-06	0.000909	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.96e-06	0.000906	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	5.41e-06	0.000822	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	5.38e-06	0.000817	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.26e-06	0.0008	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.79e-06	0.000728	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.59e-06	0.000698	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	4.57e-06	0.000695	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	4.54e-06	0.000691	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.5e-06	0.000685	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.42e-06	0.000672	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.36e-06	0.000663	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.33e-06	0.000659	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	4.3e-06	0.000653	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TH—peripheral nervous system neoplasm	4.27e-06	0.000649	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	3.88e-06	0.00059	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	3.59e-06	0.000546	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	3.51e-06	0.000533	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	3.49e-06	0.00053	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	3.44e-06	0.000523	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	3.42e-06	0.00052	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—peripheral nervous system neoplasm	2.92e-06	0.000444	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.9e-06	0.000441	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—peripheral nervous system neoplasm	2.83e-06	0.00043	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	2.75e-06	0.000418	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	2.69e-06	0.000409	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.63e-06	0.0004	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.45e-06	0.000373	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.34e-06	0.000356	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	2.32e-06	0.000353	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.31e-06	0.000351	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	2.09e-06	0.000318	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.88e-06	0.000286	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.85e-06	0.000281	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.65e-06	0.00025	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	9.47e-07	0.000144	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	9.41e-07	0.000143	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.08e-07	7.72e-05	CbGpPWpGaD
